DS
ALT icon

David Shaw’s Altimmune ALT Stock Holding History

David Shaw’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$613K Sell
201,638
-525,363
-72% -$1.57M ﹤0.01% 4075
2026
Q1 		$2.24M Sell
727,001
-616,582
-46% -$2.62M ﹤0.01% 2831
2025
Q4 		$4.85M Buy
1,343,583
+983,188
+273% +$4.29M ﹤0.01% 2326
2025
Q3 		$1.36M Buy
360,395
+309,137
+603% +$1.19M ﹤0.01% 3251
2025
Q2 		$198K Buy
51,258
+742
+1% +$4.01K ﹤0.01% 4055
2025
Q1 		$253K Sell
50,516
-409,317
-89% -$2.59M ﹤0.01% 3838
2024
Q4 		$3.32M Sell
459,833
-298,171
-39% -$2.28M ﹤0.01% 2314
2024
Q3 		$4.65M Sell
758,004
-4,358
-0.6% -$29.5K ﹤0.01% 2003
2024
Q2 		$5.07M Buy
762,362
+408,012
+115% +$3.01M ﹤0.01% 1834
2024
Q1 		$3.61M Buy
354,350
+64,624
+22% +$657K ﹤0.01% 2148
2023
Q4 		$3.26M Sell
289,726
-441,006
-60% -$1.84M ﹤0.01% 2276
2023
Q3 		$1.9M Buy
730,732
+226,494
+45% +$650K ﹤0.01% 2606
2023
Q2 		$1.78M Buy
+504,238
New +$2.26M ﹤0.01% 2700
2023
Q1 		– Sell
-27,702
Closed -$456K – 4400
2022
Q4 		$456K Buy
+27,702
New +$311K ﹤0.01% 3903
2022
Q3 		– Sell
-169,683
Closed -$1.99M – 5153
2022
Q2 		$1.99M Sell
169,683
-798,053
-82% -$4.92M ﹤0.01% 3088
2022
Q1 		$5.89M Sell
967,736
-213,501
-18% -$1.57M 0.01% 2129
2021
Q4 		$10.8M Buy
1,181,237
+225,799
+24% +$2.4M 0.01% 1599
2021
Q3 		$10.8M Buy
955,438
+127,682
+15% +$1.55M 0.01% 1463
2021
Q2 		$8.15M Sell
827,756
-488,058
-37% -$6.67M 0.01% 1669
2021
Q1 		$18.6M Buy
1,315,814
+122,120
+10% +$1.97M 0.02% 971
2020
Q4 		$13.5M Sell
1,193,694
-467,136
-28% -$5.5M 0.01% 1190
2020
Q3 		$21.9M Buy
+1,660,830
New +$33.2M 0.02% 781
2019
Q3 		– Sell
-12,300
Closed -$29K – 3785
2019
Q2 		$29K Sell
12,300
-800
-6% -$2.14K ﹤0.01% 3608
2019
Q1 		$38K Hold
13,100
– – ﹤0.01% 3526
2018
Q4 		$27K Buy
+13,100
New +$46.4K ﹤0.01% 3699

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

David Shaw's ALT Position: Q2 2026 in Review

David Shaw reduced its Altimmune (ALT) stake by 72% in Q2 2026, selling an estimated $1.57M and leaving 201,638 shares worth $613K. The position accounts for ﹤0.01% of the portfolio, ranked #4075.

David Shaw first reported a position in ALT in Q4 2018 and has held it in 25 quarters since. The position peaked at $21.9M in Q3 2020. 209 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • David Shaw held 201,638 shares of Altimmune worth $613K as of Q2 2026.
  • David Shaw sold 525,363 Altimmune shares in Q2 2026, an estimated $1.57M.
  • Altimmune made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #4075 holding.
  • David Shaw first reported a position in Altimmune in Q4 2018 and has held it in 25 quarters since.
  • David Shaw's Altimmune position peaked at $21.9M in Q3 2020.
  • 209 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.